Dopamine agonists for negative symptoms in schizophrenia.
作者信息
King D J
出版信息
Br J Clin Pharmacol. 1978 Dec;6(6):541-2. doi: 10.1111/j.1365-2125.1978.tb00882.x.
Abstract
摘要
相似文献
1
Dopamine agonists for negative symptoms in schizophrenia.用于治疗精神分裂症阴性症状的多巴胺激动剂。
Br J Clin Pharmacol. 1978 Dec;6(6):541-2. doi: 10.1111/j.1365-2125.1978.tb00882.x.
2
Bromocriptine for "negative" schizophrenia.溴隐亭治疗“阴性”精神分裂症。
Compr Psychiatry. 1991 May-Jun;32(3):210-6. doi: 10.1016/0010-440x(91)90041-a.
3
[Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
Ann Med Psychol (Paris). 1995 Oct;153(8):531-4.
4
Use of bromocriptine to prevent puerperal lactation during neuroleptic treatment of chronic schizophrenia.在慢性精神分裂症的抗精神病药物治疗期间使用溴隐亭预防产后泌乳。
Pharmacopsychiatry. 1992 Sep;25(5):240-2. doi: 10.1055/s-2007-1014413.
5
Bromocriptine, dopamine and glaucoma.溴隐亭、多巴胺与青光眼
Postgrad Med J. 1986 Sep;62(731):819-20. doi: 10.1136/pgmj.62.731.819.
6
[Dopanergic agonists and schizophrenia].[多巴胺能激动剂与精神分裂症]
Psychiatr J Univ Ott. 1989 Nov;14(4):529-35.
7
8
The use of dopamine agonists in the treatment of schizophrenia.
Neuropharmacology. 1981 Dec;20(12B):1309-13.
9
Treatment of Schizophrenia with ergot derivatives.用麦角衍生物治疗精神分裂症。
Psychopharmacology (Berl). 1979;66(3):239-42. doi: 10.1007/BF00428312.
10
Bromocriptine in augmentation of antipsychotic response in chronic schizophrenia: a negative pilot report.溴隐亭增强慢性精神分裂症患者抗精神病药物反应：一项阴性初步报告。
Pharmacopsychiatry. 1991 Jul;24(4):118-20. doi: 10.1055/s-2007-1014453.
引用本文的文献
1
Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials.精神分裂症阴性症状的药物干预：随机对照试验的系统评价
Biomedicines. 2025 Feb 21;13(3):540. doi: 10.3390/biomedicines13030540.
本文引用的文献
1
A simple and reliable subclassification of chronic schizophrenia.慢性精神分裂症的一种简单可靠的亚分类。
J Ment Sci. 1961 Sep;107:862-75. doi: 10.1192/bjp.107.450.862.
2
Central dopamine turnover in schizophrenic syndromes.精神分裂症综合征中的中枢多巴胺周转
Arch Gen Psychiatry. 1974 Jul;31(1):50-4. doi: 10.1001/archpsyc.1974.01760130034005.
3
Schizophrenia and tardive dyskinesia: is schizophrenia also a "denervation hypersensitivity"?精神分裂症与迟发性运动障碍：精神分裂症也是一种“去神经超敏反应”吗？
Med Hypotheses. 1977 Sep-Oct;3(5):207-10. doi: 10.1016/0306-9877(77)90008-1.
4
Double blind trial of L-dopa in chronic schizophrenia.左旋多巴治疗慢性精神分裂症的双盲试验。
Aust N Z J Psychiatry. 1975 Dec;9(4):269-71. doi: 10.3109/00048677509159861.
5
Bromocriptine in Parkinsonism.溴隐亭治疗帕金森病
Br Med J. 1978 May 27;1(6124):1402-4. doi: 10.1136/bmj.1.6124.1402.
6
Increased dopamine-receptor sensitivity in schizophrenia.精神分裂症中多巴胺受体敏感性增加。
Lancet. 1978 Jul 29;2(8083):223-6. doi: 10.1016/s0140-6736(78)91740-3.
7
Schizophrenia as dopamine-deficiency disease.精神分裂症作为多巴胺缺乏症。
Lancet. 1978 Jul 8;2(8080):99-100. doi: 10.1016/s0140-6736(78)91409-5.
8
Bromocriptine in Parkinson's disease.溴隐亭治疗帕金森病
Lancet. 1978 Jun 10;1(8076):1255. doi: 10.1016/s0140-6736(78)92483-2.
9
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
Lancet. 1978 Apr 22;1(8069):848-51. doi: 10.1016/s0140-6736(78)90193-9.
10
Long-term treatment of parkinsonism with bromocriptine.
Lancet. 1978 Apr 8;1(8067):735-8. doi: 10.1016/s0140-6736(78)90856-5.
Zotero 插件